This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Exosomes from myeloid-derived suppressor cells carry biologically active proteins.
J Proteome Res. 2014 Feb 7;13(2):836-43. doi: 10.1021/pr400879c. Epub 2013 Dec 13.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Exosomes from myeloid-derived suppressor cells carry biologically active proteins.
J Proteome Res. 2014 Feb 7;13(2):836-43. doi: 10.1021/pr400879c. Epub 2013 Dec 13.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Membrane microvesicles as mediators for melanoma-fibroblasts communication: Roles of the VCAM-1/VLA-4 axis and the ERK1/2 signal pathway.
Cancer Lett. 2015 Feb 4. pii: S0304-3835(15)00066-X. doi: 10.1016/j.canlet.2015.01.032.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver.
Nat Cell Biol. 2015 May 18. doi: 10.1038/ncb3169.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7A comprehensive proteomics analysis reveals a secretory path- and status-dependent signature of exosomes released from tumor associated macrophages.
J Proteome Res. 2015 Aug 27.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7A comprehensive proteomics analysis reveals a secretory path- and status-dependent signature of exosomes released from tumor associated macrophages.
J Proteome Res. 2015 Aug 27.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Cells release subpopulations of exosomes with distinct molecular and biological properties.
Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Cells release subpopulations of exosomes with distinct molecular and biological properties.
Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Cells release subpopulations of exosomes with distinct molecular and biological properties.
Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.
Oncotarget. 2016 Aug 23. doi: 10.18632/oncotarget.11535.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.
Oncotarget. 2016 Aug 23. doi: 10.18632/oncotarget.11535.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.
Oncotarget. 2016 Aug 23. doi: 10.18632/oncotarget.11535.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Macrophage Foam Cell-Derived Extracellular Vesicles Promote Vascular Smooth Muscle Cell Migration and Adhesion.
J Am Heart Assoc. 2016 Oct 17;5(10). pii: e004099.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.
Cell. 2016 Dec 1;167(6):1525-1539.e17. doi: 10.1016/j.cell.2016.11.005.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.
Cell. 2016 Dec 1;167(6):1525-1539.e17. doi: 10.1016/j.cell.2016.11.005.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Astrocyte-shed extracellular vesicles regulate the peripheral leukocyte response to inflammatory brain lesions.
Sci Signal. 2017 Apr 4;10(473). pii: eaai7696. doi: 10.1126/scisignal.aai7696.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Characterisation of adipocyte-derived extracellular vesicle subtypes identifies distinct protein and lipid signatures for large and small extracellular vesicles.
J Extracell Vesicles. 2017 Apr 10;6(1):1305677. doi: 10.1080/20013078.2017.1305677. eCollection 2017.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Hypoxia-induced changes in the fibroblast secretome, exosome, and whole-cell proteome using cultured, cardiac-derived cells isolated from neonatal mice.
J Proteome Res. 2017 Jun 22. doi: 10.1021/acs.jproteome.7b00144.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Hypoxia-induced changes in the fibroblast secretome, exosome, and whole-cell proteome using cultured, cardiac-derived cells isolated from neonatal mice.
J Proteome Res. 2017 Jun 22. doi: 10.1021/acs.jproteome.7b00144.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential.
Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential.
Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential.
Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential.
Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Differential content of proteins, mRNAs, and miRNAs suggests that MDSC and their exosomes may mediate distinct immune suppressive functions.
J Proteome Res. 2017 Nov 15. doi: 10.1021/acs.jproteome.7b00646.		ENOG410ZBX3261 / 0 / 261
Ribonuclease inhibitor (Ribonuclease/angiogenin inhibitor 1)Q91VI7Differential content of proteins, mRNAs, and miRNAs suggests that MDSC and their exosomes may mediate distinct immune suppressive functions.
J Proteome Res. 2017 Nov 15. doi: 10.1021/acs.jproteome.7b00646.		ENOG410ZBX3261 / 0 / 261
[1]